Select status:
Sort by:
Filter by last updated date

Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and June 2020

Filter by type
Showing 1 to 10 of 471
Title Reference number Published Last updated
Fremanezumab for preventing migraine Reference number:TA631 TA00631 Published:03 June 2020 20200603 Last updated:03 June 2020 20200603
Larotrectinib for treating NTRK fusion-positive solid tumours Reference number:TA630 TA00630 Published:27 May 2020 20200527 Last updated:27 May 2020 20200527
Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer Reference number:TA628 TA00628 Published:13 May 2020 20200513 Last updated:13 May 2020 20200513
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab Reference number:TA629 TA00629 Published:13 May 2020 20200513 Last updated:13 May 2020 20200513
Lenalidomide with rituximab for previously treated follicular lymphoma Reference number:TA627 TA00627 Published:07 April 2020 20200407 Last updated:07 April 2020 20200407
Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal) Reference number:TA625 TA00625 Published:04 March 2020 20200304 Last updated:04 March 2020 20200304
Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis Reference number:TA624 TA00624 Published:19 February 2020 20200219 Last updated:19 February 2020 20200219
Patiromer for treating hyperkalaemia Reference number:TA623 TA00623 Published:13 February 2020 20200213 Last updated:13 February 2020 20200213
Sotagliflozin with insulin for treating type 1 diabetes Reference number:TA622 TA00622 Published:12 February 2020 20200212 Last updated:12 February 2020 20200212
Dapagliflozin with insulin for treating type 1 diabetes Reference number:TA597 TA00597 Published:28 August 2019 20190828 Last updated:12 February 2020 20200212